Kallyope Patents – Insights & Stats

Kallyope has a total of 43 patents globally, out of which 1 have been granted. Of these 43 patents, more than 2% patents are active. The United States of America is where Kallyope has filed the maximum number of patents, followed by Pakistan and Taiwan. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Kallyope.

Kallyope was founded in 2015 by Tom Maniatis, Charles Zuker and Richard Axel. Kallyope, Inc. operates as a bio-technology company. The Company focuses on understanding gut-brain biology that will lead to transformational therapeutics to improve human health.

Do read about some of the most popular patents of Kallyope which have been covered by us in this article and also you can find Kallyope patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Kallyope patent portfolio.

How many patents does the Founder and CEO of Kallyope have?

The Founder Tom Maniatis have 2 patent, Charles Zuker have 37 patents, Richard Axel have 109 patents and CEO Jay Galeota has 0 patents.

How many patents does Kallyope have?

Kallyope has a total of 43 patents globally. These patents belong to 12 unique patent families. Out of 43 patents, 36 patents are active.

How Many Patents did Kallyope File Every Year?

Kallyope Patents Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantKallyope Applications FiledKallyope Patents Granted
202022
202117
202241

How many Kallyope patents are Alive/Dead?

Worldwide Patents

Kallyope Patents Portfolio

How Many Patents did Kallyope File in Different Countries?

Kallyope Worldwide Patents

Countries in which Kallyope Filed Patents

CountryPatents
United States Of America6
Pakistan5
Taiwan5
Uruguay5
Argentina4
Australia2
Canada2
Europe1
Israel1
India1
New Zealand1

Where are Research Centers of Kallyope Patents Located?

Research Centers of Kallyope Patents

What Percentage of Kallyope US Patent Applications were Granted?

Kallyope (Excluding its subsidiaries) has filed 3 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1 have been granted leading to a grant rate of 100%.

Below are the key stats of Kallyope patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Kallyope?

Law FirmTotal ApplicationsSuccess Rate
Wilson Sonsini Goodrich & Rosati3100%

List of Kallyope Patent –

Publication NumberTitle
US11279702B2Ampk Activators
US20220226298A1Gpr40 Agonists
US20220227754A1Ampk Activators
US20220152164A1Gpcr Combination Therapies
US20220153719A1Gpr119 Agonists
US20220002317A1Ampk Activators
EP3976576A1Gpr40 Agonists
WO2021263039A1Ampk Activators
WO2021236617A1Ampk Activators
WO2021174046A1Gpr40 Agonists
WO2021174048A1Gpr40 Agonists
WO2021113362A1Sstr5 Antagonists
WO2021113368A1Sstr5 Antagonists
WO2021113363A1Sstr5 Antagonists
WO2021071837A1Gpr119 Agonists
WO2020242943A1Gpr40 Agonists
WO2020197926A1Gpcr Combination Therapies
AU2020398874A1Sstr5 Antagonists
AU2020363377A1Gpr119 Agonists
CA3163243A1Sstr5 Antagonists
CA3156985A1Gpr119 Agonists
IL291985D0Gpr119 Agonists
IN202217025562AGpr119 Agonists
NZ786879AGpr119 Agonists
AR121485A1Gpr40 Agonists
AR121484A1Gpr40 Agonists
AR120652A1Sstr5 Antagonists
AR120167A1Gpr119 Agonists
UY39222AAmpk Activators
UY39106AAgonists Of Gpr40.
UY39107AGpr40 Agonists
UY38976ASstr5 Antagonists
UY38908AGpr119 Agonists
TW202208360AAmpk Activators
TW202140440AGpr40 Agonists
TW202140424AGpr40 Agonists
TW202134248ASstr5 Antagonists
TW202128640AGpr119 Agonists
PK202100361A0Ampk Activators
PK202100164A0“Gpr40 Agonists”
PK202100163A0“Gpr40 Agonists”
PK202000807A0Sstr5 Antagonists
PK202000681A0“Gpr119 Agonists”

EXCLUSIVE INSIGHTS COMING SOON!

What are Kallyope key innovation segments?

What Technologies are Covered by Kallyope?

The chart below distributes patents filed by Kallyope in different countries on the basis of the technology protected in patents. It also represents the markets where Kallyope thinks it’s important to protect particular technology inventions.

R&D Focus: How has Kallyope search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Kallyope?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.